Michael N. Hall is this year's recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell's growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.

中文翻译：

---

TOR，细胞代谢，细胞生长和疾病的门户。

迈克尔·N·霍尔（Michael N. Hall）因确定雷帕霉素（TOR）的靶标而获得了今年的拉斯克基础医学研究奖（Lasker Basic Medical Research Award）。TOR是细胞生长和代谢状态的主要调节剂，其失调会导致多种疾病，包括糖尿病，肥胖症，神经退行性疾病，衰老和癌症，从而使TOR途径成为有吸引力的治疗靶点。